Hims & Hers, a popular telehealth company, has recently seen its stocks plummet after a bombshell partnership exit from pharmaceutical giant Novo Nordisk.
The update, which comes as a shock for the current pharmaceutical scene, follows Novo Nordisk's allegations that Hims & Hers released counterfeit products and engaged in deceptive marketing practices.
